ada guidelines dpp4 and glp 1 Inhibitors vs GLP-1 Agonists | June 2021 | Clinical Corner 2026 Diabetes Treatment Guidelines Update:
Description
Regular Monitoring: Have periodic check-ups to monitor your progress and side effects
10.1053/j.gastro.2006.05.055 56 DunningB.FoleyJ.AhrnB
Vision Loss (NAION) Documentation If you are filing for vision loss, your case relies on ophthalmology-specific imaging: OCT (Optical Coherence Tomography): Scans showing optic nerve head edema (swelling)
Patti, M
Drug Des Devel Ther 2024;18:255570
This suggests that the GIP receptor activation in tirzepatide may provide some protection against the nausea that pure GLP-1 stimulation causes
